Mark S. Carey

A Phase 3 Trial of Bevacizumab in Ovarian Cancer

Timothy Perren, Ann Marie Swart, Jacobus Pfisterer et al. · New England Journal of Medicine · 2011 · 2.2K citations · Full text

Medicine, Oncology, Pharmacology +11

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

Amit M. Oza, Adrian Cook, Jacobus Pfisterer et al. · The Lancet Oncology · 2015 · 867 citations · Full text

Medicine, Gynecology, Oncology +15

Predictors of Large Esophageal Varices in Patients With Cirrhosis

Naga Chalasani, Thomas F. Imperiale, Ayaaz Ismail et al. · The American Journal of Gastroenterology · 1999 · 219 citations

Medicine, Clinical Sciences, Internal Medicine +17

The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers - a study of the National Cancer Institute of Canada Clinical Trials Group

Amit M. Oza, Elizabeth A. Eisenhauer, G. Stanimir et al. · International Journal of Gynecological Cancer · 2004 · 157 citations

Medicine, Oncology, Pharmacology +17

Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial

Dan Stark, Matthew Nankivell, Éric Pujade-Lauraine et al. · The Lancet Oncology · 2013 · 137 citations

Medicine, Gynecology, Oncology +12